Related Experiment Video
Updated: Jul 11, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro
Najma Bhat1, Angela Joe, Mercio PereiraPerrin
1Division of Geographic Medicine and Infectious Diseases, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Abstract:
Cryptosporidium sp. cause human and animal diarrheal disease worldwide. The molecular mechanisms underlying Cryptosporidium attachment to, and invasion of, host cells are poorly understood. Previously, we described a surface-associated Gal/GalNAc-specific lectin activity in sporozoites of Cryptosporidium parvum. Here we describe p30, a 30-kDa Gal/GalNAc-specific lectin isolated from C. parvum and Cryptosporidium hominis sporozoites by Gal-affinity chromatography. p30 is encoded by a single copy gene containing a 906-bp open reading frame, the deduced amino acid sequence of which predicts a 302-amino acid, 31.8-kDa protein with a 22-amino acid N-terminal signal sequence. The p30 gene is expressed at 24-72 h after infection of intestinal epithelial cells. Antisera to recombinant p30 expressed in Escherichia coli react with an approximately 30-kDa protein in C. parvum and C. hominis. p30 is localized to the apical region of sporozoites and is predominantly intracellular in both sporozoites and intracellular stages of the parasite. p30 associates with gp900 and gp40, Gal/GalNAc-containing mucin-like glycoproteins that are also implicated in mediating infection. Native and recombinant p30 bind to Caco-2A cells in a dose-dependent, saturable, and Gal-inhibitable manner. Recombinant p30 inhibits C. parvum attachment to and infection of Caco-2A cells, whereas antisera to the recombinant protein also inhibit infection. Taken together, these findings suggest that p30 mediates C. parvum infection in vitro and raise the possibility that this protein may serve as a target for intervention.
Insights
A newly identified protein, p30, acts as a Gal/GalNAc-specific lectin in Cryptosporidium parvum and Cryptosporidium hominis. This protein mediates parasite attachment and infection of host cells, suggesting it as a potential target for therapeutic intervention against cryptosporidiosis.
Area of Science:
- Microbiology
- Parasitology
- Molecular Biology
Background:
- Cryptosporidium species are significant global causes of diarrheal disease in humans and animals.
- The precise molecular mechanisms of Cryptosporidium attachment to and invasion of host cells remain largely unelucidated.
- Previous research identified Gal/GalNAc-specific lectin activity on the surface of Cryptosporidium parvum sporozoites.
Purpose of the Study:
- To isolate and characterize a specific lectin involved in Cryptosporidium infection.
- To investigate the role of this lectin in the attachment and invasion of host cells by Cryptosporidium parasites.
- To explore the potential of this lectin as a therapeutic target for cryptosporidiosis.
Main Methods:
- Isolation of a 30-kDa Gal/GalNAc-specific lectin (p30) from Cryptosporidium parvum and Cryptosporidium hominis sporozoites using Gal-affinity chromatography.
- Gene sequencing and analysis to determine the protein's structure and predict its characteristics.
- Expression of recombinant p30 in Escherichia coli and generation of antisera for immunological detection.
- Localization studies of p30 within parasite stages and its association with other surface glycoproteins.
- In vitro assays using Caco-2A cells to assess the binding and inhibitory effects of native and recombinant p30, as well as anti-p30 antisera.
Main Results:
- A 30-kDa Gal/GalNAc-specific lectin, designated p30, was successfully isolated from C. parvum and C. hominis sporozoites.
- The p30 gene encodes a 31.8-kDa protein with a predicted N-terminal signal sequence; gene expression occurs during intestinal epithelial cell infection.
- p30 was found to associate with other mucin-like glycoproteins (gp900 and gp40) and is localized to the apical region of sporozoites and intracellular stages.
- Both native and recombinant p30 demonstrated dose-dependent, saturable, and Gal-inhibitable binding to Caco-2A cells.
- Recombinant p30 and antisera against it significantly inhibited C. parvum attachment to and infection of Caco-2A cells in vitro.
Conclusions:
- The p30 protein plays a crucial role in mediating the attachment and infection of host intestinal epithelial cells by Cryptosporidium parvum.
- p30's specific binding to Gal/GalNAc residues suggests a key mechanism for parasite-host cell recognition.
- These findings highlight p30 as a potential therapeutic target for developing novel interventions against cryptosporidiosis.
Related Concept Videos
Amebiasis
Giardiasis

